CHAPTER 19 – Membranous Nephropathy

[1]  D. Cattran,et al.  Renal pathology in idiopathic membranous nephropathy: a new perspective. , 2006, Kidney international.

[2]  F. Lai,et al.  Lamivudine in hepatitis B-associated membranous nephropathy. , 2005, Kidney international.

[3]  Andrey V Cybulsky,et al.  Experimental membranous nephropathy redux. , 2005, American journal of physiology. Renal physiology.

[4]  D. Cattran.  Management of membranous nephropathy: when and what for treatment. , 2005, Journal of the American Society of Nephrology : JASN.

[5]  Emile de Heer,et al.  Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies , 2004, The Lancet.

[6]  J. Cameron.  Membranous nephropathy in childhood and its treatment , 1990, Pediatric Nephrology.

[7]  A. Eddy,et al.  Nephrotic syndrome in childhood , 2003, The Lancet.

[8]  S. Makker.  Treatment of membranous nephropathy in children. , 2003, Seminars in nephrology.

[9]  G. Filler,et al.  Another case of HBV associated membranous glomerulonephritis resolving on lamivudine , 2003, Archives of disease in childhood.

[10]  H. Coovadia,et al.  Treatment of hepatitis B virus-associated nephropathy in black children , 2002, Pediatric Nephrology.

[11]  N. Muirhead.  Management of idiopathic membranous nephropathy: evidence-based recommendations. , 1999, Kidney international. Supplement.

[12]  K. Budde,et al.  Treatment of membranous glomerulopathy with cyclosporin A: how much patience is required? , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  J. Wetzels,et al.  Prognostic factors in idiopathic membranous nephropathy. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  H. Coovadia,et al.  Nephrotic syndrome in South African children: changing perspectives over 20 years , 1997, Pediatric Nephrology.

[15]  M. Raftery,et al.  Urinary C5b-9 excretion and clinical course in idiopathic human membranous nephropathy. , 1995, Kidney international.

[16]  F. Locatelli,et al.  A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. , 1995, Kidney international.

[17]  R. Falk,et al.  A review of therapeutic studies of idiopathic membranous glomerulopathy. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  D. Churchill,et al.  A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group. , 1995, Kidney international.

[19]  C. Y. Lin,et al.  Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon. , 1995, Kidney international.

[20]  D. Kerjaschki.  Molecular pathogenesis of membranous nephropathy. , 1992, Kidney international.

[21]  C. Y. Lin,et al.  Hepatitis B virus-associated membraneous nephropathy: clinical features, immunological profiles and outcome. , 1990, Nephron.

[22]  H. Hsu,et al.  Membranous nephropathy in 52 hepatitis B surface antigen (HBsAg) carrier children in Taiwan. , 1989, Kidney international.

[23]  T. Yoshiki,et al.  Glomerular deposition of C4 cleavage fragment (C4d) and C4-binding protein in idiopathic membranous glomerulonephritis. , 1989, Nephron.

[24]  V. Bonomini,et al.  Idiopathic membranous nephropathy in 2 twin brothers. , 1988, Nephron.

[25]  S. Adler,et al.  Electrical charge. Its role in the pathogenesis and prevention of experimental membranous nephropathy in the rabbit. , 1983, The Journal of clinical investigation.

[26]  J. Manos,et al.  Clinical membranous nephropathy. , 1983, Nephron.

[27]  S. Poucell,et al.  Idiopathic membranous glomerulopathy in Canadian children: a clinicopathologic study. , 1982, The Journal of pediatrics.